Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Twist Bioscience Corp
Report date April 01, 2021 · Filed April 07, 2021
Section 16 reporting ended · disclosed 2021-04-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,736 |
Reported balance
After 2021-04-01 transaction · row 1
1 source rowRow 1 · 2021-04-01 · Tax withholding · Disposed 190 · Balance 66,736 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,500 | $66.00 | $495,000.00 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · nonDerivative · entry 5 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,224 Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 9,006 | $5.95 | $53,585.70 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · nonDerivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,502 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · derivative · entry 7 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,878 Underlying: Common Stock · 14,502 shares Expires 2026-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,002 | $64.03 | $448,338.06 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · nonDerivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,718 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,500 | $65.00 | $487,500.00 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,720 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 14,502 | $5.95 | $86,286.90 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,536 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-005740 · marketforms-49043.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,380 Underlying: Common Stock · 3,536 shares Expires 2026-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,536 | $38.80 | $137,181.24 |
DisclosureSEC source: 0001214659-20-005740 · marketforms-49043.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,718 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $38.75 to $38.92 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,536 | $5.95 | $21,039.20 |
DisclosureSEC source: 0001214659-20-005740 · marketforms-49043.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,962 | $40.00 | $78,480.00 |
DisclosureSEC source: 0001214659-20-005546 · marketforms-49024.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,718 Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:08 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 519 | $39.76 | $20,635.44 |
DisclosureSEC source: 0001214659-20-004970 · marketforms-48850.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,680 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 23:59 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 519 | $33.13 | $17,194.47 |
DisclosureSEC source: 0001214659-20-001753 · marketforms-47849.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,711 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 20, 2019 Filed Nov 21, 2019 23:34 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,075 | $22.85 | $47,413.75 |
DisclosureSEC source: 0001214659-19-007343 · marketforms-46379.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,230 Read SEC document |
| October 24, 2019 Filed Nov 6, 2019 02:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 29,780 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001209191-19-055405 · doc4.xml · derivative · entry 2 Daniels Mark · CIK 0001753840 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,780 Underlying: Common Stock · 29,780 shares Expires 2029-10-23 F2 · derivative.exercise_date: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date. Read SEC document |
| October 24, 2019 Filed Nov 6, 2019 02:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 6,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055405 · doc4.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,305 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:37 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,500 | $29.90 | $44,850.00 |
DisclosureSEC source: 0001209191-19-049888 · doc4.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,355 Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 22:41 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001209191-18-059796 · doc4.xml · derivative · entry 2 Daniels Mark · CIK 0001753840 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2028-11-18 F2 · derivative.exercise_date: 12/60th of the shares subject to the option vest and become exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 22:41 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-059796 · doc4.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · SVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,355 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 12/60th of the shares subject to the RSU Award vesting on November 20, 2019 and 1/20th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.